Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial
In an attempt to produce a more defined, clinical-grade version of a vaccine based on Plasmodium falciparum merozoite surface protein 1 (MSP1), we evaluated the efficacy of two recombinant forms of MSP1 in an Aotus nancymai challenge model system. One recombinant vaccine, bvMSP1(42), based on the 42...
Guardat en:
| Publicat a: | Infect Immun |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2001
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC98053/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11179324/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.3.1536-1546.2001 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
